Uveal melanoma: epidemiology, etiology, and treatment of primary disease

Por Krantz, Benjamin A, Dave, Nikita, Komatsubara, Kimberly M, Marr, Brian P, Carvajal, Richard D
Publicado no Clin Ophthalmol (2017)

Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function

Por Wong, Deborah J.L., Rao, Amol, Avramis, Earl, Matsunaga, Douglas R., Komatsubara, Kimberly M., Atefi, Mohammad S., Escuin-Ordinas, Helena, Chodon, Thinle, Koya, Richard C., Ribas, Antoni, Comin-Anduix, Begoña
Publicado em 2014

The Role of Oncolytic Viruses in the Treatment of Melanoma

Por Bayan, Claire-Audrey Y., Lopez, Adriana T., Gartrell, Robyn D., Komatsubara, Kimberly M., Bogardus, Margaret, Rao, Nisha, Chen, Cynthia, Hart, Thomas D., Enzler, Thomas, Rizk, Emanuelle M., Pradhan, Jaya Sarin, Marks, Douglas K., Geskin, Larisa J., Saenger, Yvonne M.
Publicado no Curr Oncol Rep (2018)

Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment (TIME) and identifies a combination biomarker for primary melanoma

Por Gartrell-Corrado, Robyn D., Chen, Andrew X., Rizk, Emanuelle M., Marks, Douglas K., Bogardus, Margaret H., Hart, Thomas D., Silverman, Andrew M., Bayan, Claire-Audrey Y., Finkel, Grace G., Barker, Luke W., Komatsubara, Kimberly M., Carvajal, Richard D., Horst, Basil A., Chang, Rui, Monod, Anthea, Rabadan, Raul, Saenger, Yvonne M.
Publicado no Cancer Res (2020)